Skip to main content

Year: 2020

NIBE proposes a dividend of SEK 1.40 per share

The Board of Directors of NIBE Industrier proposes a dividend of SEK 1.40 per share for the 2019 financial year. The proposal will be taken up at an extraordinary general meeting on 16 December 2020.As a precautionary measure and to form a better picture of the consequences of Covid-19 regarding demand, delivery and results, the Board resolved on 30 March 2020 to recall the original dividend proposal of SEK 1.40 per share and instead call an extraordinary general meeting later in the year to decide on the issue of a dividend for 2019.Given the Company’s continued strong position regarding both capital and liquidity, the Board has now determined that conditions are favourable enough to reintroduce the original dividend proposal.Due to the prevailing conditions, the extraordinary general meeting will be held without the physical presence...

Continue reading

NIBE föreslår en utdelning om 1,40 kr per aktie

Styrelsen för NIBE Industrier föreslår en utdelning om 1,40 kr per aktie för räkenskapsåret 2019. Förslaget kommer att behandlas vid en extra bolagsstämma den 16 december 2020.Som en försiktighetsåtgärd och för att bättre kunna överblicka konsekvenserna av Covid-19 vad gäller efterfrågan, leveranser och resultat, beslöt styrelsen den 30 mars 2020 att återkalla sitt ursprungliga utdelningsförslag om 1,40 kr per aktie och att istället kalla till en extra bolagsstämma senare under året för beslut i frågan om utdelning för 2019.Styrelsen har nu, givet bolagets fortsatt starka ställning avseende såväl eget kapital som likviditet, bedömt att förutsättningarna föreligger för att återinföra det ursprungliga utdelningsförslaget.Till följd av rådande omständigheter kommer den extra bolagsstämman att hållas utan fysisk närvaro av aktieägare. Det...

Continue reading

ReveraGen Receives $3.3 Million NIH Commercialization Readiness Pilot Grant for NDA Preparations for Vamorolone in Duchenne Muscular Dystrophy

— Funds will support NDA preparatory activities for anticipated filing in 2021 —November 17, 2020, 08:30 AM Eastern TimeRockville, Maryland—ReveraGen, Inc., a privately held company developing vamorolone (VBP15) as a potential safer alternative for corticosteroid treatment in Duchenne muscular dystrophy and other disorders, today announced an award of a $3.3 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) at National Institutes of Health (NIH). The two-year SBIR/STTR Commercialization Readiness Pilot (CRP) Program award will provide additional funding towards the new drug application (NDA) preparation, enabling timely filing after the read-out of the fully-enrolled registration study (VBP15-004; NCT03439670) anticipated in Q2 2021.The Commercialization Readiness Pilot (CRP) program is...

Continue reading

ReveraGen Receives $3.3 Million NIH Commercialization Readiness Pilot Grant for NDA Preparations for Vamorolone in Duchenne Muscular Dystrophy

— Funds will support NDA preparatory activities for anticipated filing in 2021 —November 17, 2020, 08:30 AM Eastern Time (press release provided in english only)Rockville, Maryland—ReveraGen, Inc., a privately held company developing vamorolone (VBP15) as a potential safer alternative for corticosteroid treatment in Duchenne muscular dystrophy and other disorders, today announced an award of a $3.3 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) at National Institutes of Health (NIH). The two-year SBIR/STTR Commercialization Readiness Pilot (CRP) Program award will provide additional funding towards the new drug application (NDA) preparation, enabling timely filing after the read-out of the fully-enrolled registration study (VBP15-004; NCT03439670) anticipated in Q2 2021.The Commercialization...

Continue reading

UBISOFT’S ASSASSIN’S CREED VALHALLA IS THE BIGGEST ASSASSIN’S CREED GAME LAUNCH IN HISTORY

UBISOFT’S ASSASSIN’S CREED VALHALLAIS THE BIGGEST ASSASSIN’S CREED GAME LAUNCH IN HISTORYThe Premiere Next-Gen Title Sold Through More Units in First Week Than Any Other Assassin’s Creed GameBiggest PC Launch Ever for a Ubisoft GameDownload the Press ReleaseParis, France — November 17, 2020 — Today, Ubisoft® announced strong early sales for Assassin’s Creed® Valhalla, one of the highest rated games this season1. Building on favorable review scores and early player response, Assassin’s Creed Valhalla has sold through more units in its first week than any other Assassin’s Creed game sold during the same period.  Assassin’s Creed Valhalla has also become the top-selling Ubisoft PC launch ever, driven by all-time record Ubisoft Store sales performance. With strong feedback from players on next-gen consoles, ACV is delivering on its promise...

Continue reading

Brunswick Resources Signs Letter of Intent to Acquire Poko Group Ltd.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.ROUYN-NORANDA, Quebec, Nov. 17, 2020 (GLOBE NEWSWIRE) — Brunswick Resources Inc. (TSX-V: BRU.H) (“Brunswick” or the “Corporation”) and POKO Group Ltd. (“Poko”) are pleased to announce that they have entered into a binding letter of intent (the “LOI”) to complete a business combination transaction (the “Proposed Transaction”) that will result in the reverse take-over of Brunswick by Poko. The entity resulting from the Proposed Transaction (the “Resulting Issuer“) will continue to carry on the business of Poko. The LOI was negotiated at arm’s length and is dated November 16, 2020.Description of PokoPoko is a UK-based CBD company that leverages its strong portfolio of brands,...

Continue reading

Verizon and Snap Inc. debut first-ever 5G Landmarker Lens

The Lens, exclusive to 5G Ultra Wideband customers, transforms the New York Public Library through AR for an experience like no otherWhat you need to know:Verizon and Snap Inc. are launching the first-ever 5G Landmarker Lens, an augmented reality experience exclusively for Verizon 5G Ultra Wideband customers.The 5G Landmarker Lens uses augmented reality to deliver a musical performance from the Grammy®nominated band Black Pumas at the New York Public Library.Experience features the first full-length song ever used in a Snapchat augmented reality Lens, and the virtual performance was shot by Verizon Media’s RYOT in the first and only 5G production studio in the country.NEW YORK, Nov. 17, 2020 (GLOBE NEWSWIRE) — Verizon and Snap Inc. today released the first-ever 5G-enabled Landmarker Lens exclusively for Verizon 5G Ultra Wideband...

Continue reading

Victory Square Technologies Portfolio Company Enters into a Key Business Development & Sales Agreement for its Safetest Covid-19 Rapid and other Tests with Molkom Pharmaceuticals

Molkom has over 24 years of experience representing pharmaceutical companies in Brazil and over 14 years in Latin America. The company boasts over 45,000 professional contacts worldwide, 5500 plus direct access to buyers and sales and development contracts totaling over $250,000,000 CAD.*Molkom has ability and capacity to grow current sales and distribution networks for Safetest Covid-19 Rapid and other Tests through direct connection to the global biotech marketplaceThis is a critical agreement for Victory Square Health to increase sales of its Safetest Covid-19 Rapid Test products globallyVANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) — Victory Square Health Inc. (“VS Health” or the “Company“) – a portfolio company of Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) — is pleased...

Continue reading

IT Link : recul de 8,5% du chiffre d’affaires au T3 2020

 Communiqué FinancierLe Kremlin-Bicêtre, le 17 novembre 2020Le chiffre d’affaires du Groupe confirme la reprise progressive de l’activité malgré une décroissance sur le T3 20203ème trimestreSur 9 moisRépartition par nature d’activité sur 9 mois(1)  Information non auditéeUne tendance à fin septembre moins marquée par l’impact de la crise sanitaireDepuis le mois de juillet, la reprise progressive de l’activité se confirme. Le chiffre d’affaires du 3ème trimestre affiche un retrait de 8,5% par rapport à 2019, contre une baisse de 20,2% du chiffre d’affaires au 2nd trimestre.Sur 9 mois, la France connaît une décroissance de 6,7% de son chiffre d’affaires. Le redémarrage des activités services et le dynamisme des équipes commerciales ont permis d’atténuer en partie les effets de la crise sanitaire.A l’international, le chiffre d’affaires...

Continue reading

NoHo Partners Plc: Managers’ transactions (Nurminen)

NoHo Partners PlcMANAGERS’ TRANSACTIONS 17 November 2020 at 19:30NoHo Partners Plc: Managers’ transactions (Nurminen)In total the disposals reported above are 5,414 shares.Additional information:Jarno Vilponen, CFO, NoHo Partners Plc, tel. +358 40 721 9376Distribution:Nasdaq HelsinkiMajor mediawww.noho.fiNoHo Partners Plc is a Finnish group established in 1996, specialising in restaurant services. The company, which was listed on NASDAQ Helsinki in 2013 and became the first Finnish listed restaurant company, has continued to grow strongly throughout its history. The Group companies include some 250 restaurants in Finland, Denmark and Norway. The well-known restaurant concepts of the company include Elite, Savoy, Teatteri, Yes Yes Yes, Stefan’s Steakhouse, Palace, Löyly, Hanko Sushi, Friends & Brgrs and Cock’s & Cows....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.